Otoferlin Gene-Mediated Hearing Loss – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Hearing loss is one of the most frequent congenital sensory disorders, affecting one out of every 500 newborns having bilateral hearing loss. It is reported that 50% - 60% of these cases show a genetic etiology, with 80% demonstrating autosomal recessive hearing loss. The OTOF gene, encoding otoferlin, is reported to be one of the frequent causes of non-syndromic recessive sensorineural hearing loss. Thelansis’s “Otoferlin Gene-Mediated Hearing Loss Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Otoferlin Gene-Mediated Hearing Loss treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of Otoferlin Gene-Mediated Hearin...